Pharmaceutical
Representative Clients
Marshall, Gerstein & Borun’s pharmaceutical practice group provides comprehensive services to pharmaceutical entities of all sizes, from industry leaders to small generic pharmaceutical companies. Our experience in obtaining and enforcing intellectual property rights for successful commercial products allows us to integrate legal strategies with a client's business goals.
Our team includes attorneys and patent agents with undergraduate and advanced degrees, including doctorates, in chemistry, biochemistry, chemical engineering, the biological sciences or related scientific disciplines. Many also have industry experience in chemical - or pharmaceutical-related fields. In addition, many of our attorneys possess substantial experience in pharmaceutical patent litigation, including litigation relating to the Hatch-Waxman Act and its provisions concerning Abbreviated New Drug Applications (ANDAs), as well as related drug and biologic applications reviewed by the Food and Drug Administration.
Our scope of services includes:
- Procuring patents (including reexaminations, reissues and patent term extensions)
- Managing, evaluating and licensing patent portfolios
- Counseling clients concerning validity, infringement and patentability
- Due diligence for licensing or public offerings
- Enforcing patents and defending clients in patent infringement suits in the U.S. and abroad
- Representing clients in interferences, oppositions, litigation and other inter partes proceedings in the U.S. and throughout the world
Representative Clients
- Amgen Inc.
- Hospira, Inc.
- ICOS Corporation
- JRS Pharma LP
- Novartis AG
- Nycomed Danmark ApS
- Penwest Pharmaceuticals Co.
- Pfizer Inc.
- Serono, Inc.
